Schedule 13G ownership disclosure

REDHILL BIOPHARMA LTD

Security class unavailable · CUSIP: 757468103

Event date: 2016-12-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,195,123
Percent of class
11.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-17-000018
Form type
SC 13G
Filer
EMC2 Fund Ltd.
CIK
CIK 1693705
Filed
Jan 06, 2017
Reporting period
Dec 27, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub